Your browser doesn't support javascript.
loading
Neutrophil-dendritic cell interaction plays an important role in live attenuated Leishmania vaccine induced immunity.
Bhattacharya, Parna; Ismail, Nevien; Saxena, Ankit; Gannavaram, Sreenivas; Dey, Ranadhir; Oljuskin, Timur; Akue, Adovi; Takeda, Kazuyo; Yu, James; Karmakar, Subir; Dagur, Pradeep K; McCoy, John Philip; Nakhasi, Hira L.
  • Bhattacharya P; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Ismail N; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Saxena A; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Gannavaram S; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Dey R; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Oljuskin T; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Akue A; Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Takeda K; Division of Blood Components and Devices, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Yu J; Division of Blood Components and Devices, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Karmakar S; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Dagur PK; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • McCoy JP; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Nakhasi HL; Division of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research Food and Drug Administration, Silver Spring, Maryland, United States of America.
PLoS Negl Trop Dis ; 16(2): e0010224, 2022 02.
Article en En | MEDLINE | ID: mdl-35192633

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leishmania donovani / Vacunas contra la Leishmaniasis / Leishmaniasis Visceral Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leishmania donovani / Vacunas contra la Leishmaniasis / Leishmaniasis Visceral Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article